BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33633689)

  • 1. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.
    Dou Y; Chen Y; Hu D; Su X
    Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Na YM; Cho JS; Park MH
    Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
    Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
    Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
    Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
    Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study.
    Xiao L; Wu J; Jiang L; Xu Y; Liu B
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):413-418. PubMed ID: 34398464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.
    Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY
    Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
    Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K
    Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
    Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
    Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Ahn D; Lee GJ; Sohn JH; Jeon JH
    Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
    Zhang Q; Zhong ZZ; Wu T; He YQ
    BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
    Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL
    Am J Surg; 2020 Nov; 220(5):1169-1173. PubMed ID: 32684294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.
    Baran JA; Bauer AJ; Halada S; Mostoufi-Moab S; Isaza A; Robbins S; Franco AT; Adzick NS; Patel T; Kazahaya K
    Thyroid; 2021 Dec; 31(12):1786-1793. PubMed ID: 34714171
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer.
    Park S; Jeon MJ; Oh HS; Lee YM; Sung TY; Han M; Han JM; Kim TY; Chung KW; Kim WB; Shong YK; Kim WG
    Thyroid; 2018 Aug; 28(8):997-1003. PubMed ID: 29845894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
    Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
    Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients.
    Cho JW; Lee YM; Lee YH; Hong SJ; Yoon JH
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):100-109. PubMed ID: 29672893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.